New Arrival Knk437, Hsp70 Inhibitor (tbi5561) + Free Return [4VOgHFDZ]

KNK437: Advanced HSP70 Inhibitor

Discover the power of KNK437, a cutting-edge HSP70 inhibitor designed to revolutionize your research. This potent compound boasts a molecular formula of C₁₃H₁₁NO₄ and a formula weight of 245.20, ensuring high purity and reliability. With a CAS number of 218924-25-5 and a purity level exceeding 98%, KNK437 is the ideal choice for your experiments. Its formulation as a powder and solubility in DMSO (30 mg/ml) make it convenient and versatile for various applications.

Product Specifications and Features

KNK437 is a true powerhouse in the field of HSP70 inhibition. Its ability to block geldanamycin-induced induction of HSP70 and inhibit TGFß signaling makes it a valuable tool in cancer research. Additionally, KNK437 inhibits leukocyte integrin α4ß7-mediated adhesion, suggesting its potential in immune system studies. Key features include a storage temperature of -20°C and stability for up to 2 years, ensuring long-term reliability.

• Purity: >98%
• Storage: -20°C
• Stability: ≥ 2 years

Applications and Benefits

KNK437 is a versatile inhibitor with a wide range of applications. Its ability to suppress morphine analgesic tolerance in rodent models demonstrates its potential in pain management research. Whether you are studying cancer, immune responses, or pain pathways, KNK437 is the perfect choice. Ideal for both non-stressed and heat-stressed cancer cells, this inhibitor is a must-have for any researcher looking to delve deeper into the complex world of HSP70 expression.

• Applications: HSP70 inhibitor, cancer research, immune system studies, pain management
• Benefits: Inhibits HSP70 expression, blocks TGFß signaling, inhibits leukocyte adhesion